Read, Watch or Listen

The Federal Trade Commission and seven states filed a contempt petition against Martin Shkreli, alleging he repeatedly violated a 2022 court order that barred him from the pharmaceutical industry for life. Shkreli, released from prison in May two thousand twenty‑two for unrelated financial crimes, reportedly traded in over sixty pharmaceutical stocks and livestreamed commentary on companies such as Vyera Pharmaceuticals. The filing requests a judge to order Shkreli to divest any current holdings and pay a fine equal to his trading profits, with potential incarceration for future breaches. FTC Commissioner Mark Meador emphasized that a lifetime ban must be enforced with commensurate penalties to deter future violations. The court order stems from a finding that Shkreli organized an anti‑competitive scheme to perpetuate his company Vyera Pharmaceuticals’ monopoly in the anti‑parasitic drug Daraprim, hiking its price from seventeen point five dollars per tablet to a whopping seven hundred

By Lauren B. | JQJO News